Duke logo

Adaptive PET II for Gynecologic and Gastrointestinal Cancers - Clinical Trial

What is the Purpose of this Study?

We are doing this study to understand the benefit of using PET scan in addition to the standard of care CT scan to plan for radiation therapy.

The PET-CT scan may allow your radiation doctor to fine tune the radiation plan or the delivery of radiation to your cancer.

What is the Condition Being Studied?

Reproductive and Digestive Cancer

Who Can Participate in the Study?

Adults who:
-Are diagnosed with cervical or vulvar (female reproductive tract), esophageal or anal canal (digestive tract) cancer
-Have a negative pregnancy test

Age Group
Adults

What is Involved?

If you choose to join this study, you will:
- have 2 PET scans in addition to computed tomography (CT) scans
- have the first PET-CT scan before the start of radiation therapy
- have the second PET-CT scan during radiation therapy
- be involved in the study for about 6-8 weeks

Study Details

Full Title
Intratreatment FDG-PET During Radiation Therapy for Gynecologic and Gastrointestinal Cancers (Adaptive PET II)
Principal Investigator
Gynecologic Cancers Specialist
Protocol Number
IRB:PRO00089619
NCT:NCT03403465
Phase
Phase N/A
ClinicalTrials.gov
Contact the Duke Recruitment Innovation Center
studyrecruitment@duke.edu
or
919-681-5698